ICARES Medicus, Inc. (TPEX:6612)

Market Cap	5.02B
Revenue (ttm)	996.44M
Net Income (ttm)	127.40M
Shares Out	42.57M
EPS (ttm)	2.97
PE Ratio	39.75
Forward PE	n/a
Dividend	0.30 (0.25%)
Ex-Dividend Date	Jul 8, 2024

Volume	9,421
Average Volume	25,981
Open	119.50
Previous Close	120.00
Day's Range	118.00 - 119.50
52-Week Range	88.50 - 177.00
Beta	0.45
RSI	42.68
Earnings Date	Aug 12, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.